Xu Xiaohong, M.S.

Position:Vice Chair of Endocrinology


Medical School:Zhejiang University School of Medicine, China

Academic Rank:Chief Physician


Clinical / Research Interests

Diagnosis and treatment of diabetes, thyroid disease and adrenal disease, especially primary hyperaldosteronism (PA). PA is the most common disease of secondary hypertension and adrenal vein sampling (AVS) is the gold standard but high-difficulty technology for localizing the overproduction of PA. The success rate of AVS at SAHZU is almost 95% -100% and Dr Xu is a chief specialist for diagnosis and treatment of PA at SAHZU.

Professional Highlights

Medicine and Health Achievements of Zhejiang Province, Second Prize

Professional Appointments

Education Experience

Research Summary

Clinical research for the pathogenesis, diagnosis and treatment of primary hyperaldosteronism, especially construction of standardized diagnosis and treatment for PA as well as promoting the development of adrenal vein sampling in SAHZU.


Li Zeng; Xiaoxiao Song; Chenhong Lin; Jon Kee Ho; Pingxiang Yu; Sanjay Jaiswal; Xiaohong Xu; Growth Hormone Replacement Therapy in Adult Growth Hormone Deficiency and Risk of Cancer: A Meta-Analysis, Open Journal of Endocrine and Metabolic Diseases, 2017, 7: 173-189. 

Xiaohong Xu; Haijuan Xiao; Jianpei Zhao; Tongfeng Zhao; Cardioprotective effect of sodium ferulate in diabetic rats, Int J Med Sci, 2012, 9(4):291-300.

Current Program

Prevalence and intervention of Human growth hormone deficiency in post-operation pituitary tumor patients. Funding Source: Zhejiang Provincial Department of Science and Technology.

Find People

Search by Family Name

Find A Department

Search by Departments